Tag: FDA generics

Post-Market Surveillance: How the FDA Monitors Generics After Approval

The FDA uses real-time data, AI, and inspections to monitor generic drugs after approval. With 90% of prescriptions filled with generics, post-market surveillance is critical to catching safety issues that clinical trials miss.